Considerable data associate transforming growth factor (TGF)-beta with glomerulosclerosis, but little is known about the intracellular signals that mediate TGF-beta effects. We propose to investigate possible fibrogenic roles for two major signal transduction pathways. TGF-betas activate at least one classical pathway, the mitogen activated protein (MAP) kinase cascade, that may mediate activation of ECM genes. A second potentially relevant pathway involves a novel, TGF-beta family-specific group of signaling proteins, the SMADs. Limited data are available regarding ligand-dependent activation of endogenous SMAD proteins, with no published data on the functional activity of these proteins in renal cell systems. Our preliminary results suggest that in human mesangial cells (l) TGF-beta1 stimulates collagen gene activation, (2) SMAD proteins are expressed and rapidly phosphorylated by TGF-beta1 treatment, (3) the ERK and JNK MAP kinases are stimulated by TGF-beta1, (4) inhibition of ERK activation decreases TGF-beta1-stimulated collagen mRNA expression (5) dominant negative mutant ERK1 and Smad3 constructs decrease TGF-beta1-induced collagen I gene promoter activity. From these data, we propose the hypothesis that both the MAP kinase and SMAD pathways are activated by TGF-beta1 in human mesangial cells and are relevant to matrix accumulation. We will test this hypothesis via four specific aims. First, we will characterize TGF-beta1 activation of the ERK and JNK MAP kinase, and SMAD, pathways, evaluating protein phosphorylation, nuclear translocation and possible interaction between the two pathways. Second, we will determine whether interrupting the SMAD or MAP kinase pathways prevents induction of expression or activation of gene promoters for type I and type IV collagen by TGF- beta1. Third, we will examine the mechanism of activation of collagen genes by identifying TGF-beta1-responsive elements in the gene promoters and determining whether MAP kinases and/or SMADs participate in transcription-regulatory complexes that bind to these DNA sequences. Finally, we will seek to relate our findings to glomerulosclerosis by determining whether SMADs and MAP kinases are expressed and activated in human disease or in animal models of glomerular collagen accumulation. These studies will provide a model for cell signaling mechanisms that mediate matrix accumulation by mesangial cells and may suggest means for altering abnormal matrix turnover in glomerulosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK049362-07
Application #
6476218
Study Section
Pathology A Study Section (PTHA)
Program Officer
Hirschman, Gladys H
Project Start
1994-09-30
Project End
2003-11-30
Budget Start
2001-12-01
Budget End
2002-11-30
Support Year
7
Fiscal Year
2002
Total Cost
$229,816
Indirect Cost
Name
Northwestern University at Chicago
Department
Pediatrics
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Baumann, Bethany; Hayashida, Tomoko; Liang, Xiaoyan et al. (2016) Hypoxia-inducible factor-1? promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3. Kidney Int 90:797-808
Liang, Xiaoyan; Schnaper, H William; Matsusaka, Taiji et al. (2016) Anti-TGF-? Antibody, 1D11, Ameliorates Glomerular Fibrosis in Mouse Models after the Onset of Proteinuria. PLoS One 11:e0155534
Schnaper, H William; Furth, Susan L; Yao, Lynne P (2015) Defining new surrogate markers for CKD progression. Pediatr Nephrol 30:193-8
Liu, Xiaoying; Hubchak, Susan C; Browne, James A et al. (2014) Epidermal growth factor inhibits transforming growth factor-?-induced fibrogenic differentiation marker expression through ERK activation. Cell Signal 26:2276-83
Schnaper, H William (2014) Remnant nephron physiology and the progression of chronic kidney disease. Pediatr Nephrol 29:193-202
Hogg, Ronald J; Friedman, Aaron; Greene, Tom et al. (2013) Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS. Clin J Am Soc Nephrol 8:211-8
Chen, Guang; Chen, Xing; Sukumar, Aravin et al. (2013) TGF? receptor I transactivation mediates stretch-induced Pak1 activation and CTGF upregulation in mesangial cells. J Cell Sci 126:3697-712
Lillehoj, Erik P; Kato, Kosuke; Lu, Wenju et al. (2013) Cellular and molecular biology of airway mucins. Int Rev Cell Mol Biol 303:139-202
Hanna, Christian; Hubchak, Susan C; Liang, Xiaoyan et al. (2013) Hypoxia-inducible factor-2* and TGF-* signaling interact to promote normoxic glomerular fibrogenesis. Am J Physiol Renal Physiol 305:F1323-31
Browne, J A; Liu, X; Schnaper, H W et al. (2013) Serine-204 in the linker region of Smad3 mediates the collagen-I response to TGF-? in a cell phenotype-specific manner. Exp Cell Res 319:2928-37

Showing the most recent 10 out of 47 publications